K. Rabe
Pulmonary and Respiratory Medicine · New England Journal of Medicine · 2004–2018
A researcher in the Science corpus: 18 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 217 citations into it; #279 of 770 by trust here, #108 by citations
- Molecular Biology — 15 citations into it; #15,504 of 17,773 by trust here, #13,284 by citations
Whom K. Rabe trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Rabe overall
Papers from K. Rabe's perspective
Ordered by how strongly the researchers K. Rabe trusts endorse each paper. Same corpus, a different order for every researcher.
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
- Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
- Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. (Chest)
- Gender and chronic obstructive pulmonary disease: why it matters.
- Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. (American Journal of Respiratory and Critical Care Medicine)
- Chronic obstructive pulmonary disease: current burden and future projections (European Respiratory Journal)
- The nature of small-airway obstruction in chronic obstructive pulmonary disease. (New England Journal of Medicine)
- Chronic obstructive pulmonary disease. (Clinical evidence)
- Systemic effects of chronic obstructive pulmonary disease (European Respiratory Journal)
Their papers
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. (2009) — 621 citations
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. (2009) — 818 citations
- Dupilumab Efficacy and Safety in Moderate‐to‐Severe Uncontrolled Asthma (2018) — 1,570 citations
- Efficacy and Safety of Dupilumab in Glucocorticoid‐Dependent Severe Asthma (2018) — 960 citations
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma (2017) — 909 citations
- Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer. (2017) — 653 citations
- Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline (2017) — 596 citations
- Management of non-small-cell lung cancer: recent developments. (2013) — 738 citations
- Tiotropium versus salmeterol for the prevention of exacerbations of COPD. (2011) — 716 citations
- Chronic obstructive pulmonary disease phenotypes: the future of COPD. (2010) — 1,052 citations
- Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. (2010) — 604 citations
- Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. (2010) — 759 citations
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * (2008) — 3,436 citations
- Complex chronic comorbidities of COPD (2008) — 703 citations
- From COPD to chronic systemic inflammatory syndrome? (2007) — 714 citations
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007) — 13,352 citations
- Burden and clinical features of chronic obstructive pulmonary disease (COPD). (2004) — 1,063 citations
- Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. (2004) — 995 citations